Human immunodeficiency virus; Human immunodeficiency virus 1; Note; T lymphocyte
Disciplines :
Immunology & infectious disease
Author, co-author :
DARCIS, Gilles ; Centre Hospitalier Universitaire de Liège - CHU > Service des maladies infectieuses - médecine interne
Coombs, R. W.; Department of Laboratory Medicine, University of Washington, Seattle, WA, United States
Van Lint, C.; Service of Molecular Virology, Département de Biologie Moléculaire (DBM), Université Libre de Bruxelles (ULB), 12 rue des Profs. Jeener et Brachet, Gosselies, Belgium
Language :
English
Title :
Exploring the anatomical HIV reservoirs: Role of the testicular tissue
Davey RT Jr, Bhat N, Yoder C, Chun TW, Metcalf JA, Dewar R, et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci U S A 1999; 96:15109-15114.
Nickle DC, Jensen MA, Shriner D, Brodie SJ, Frenkel LM, Mittler JE, et al. Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments. J Virol 2003; 77:5540-5546.
Churchill MJ, Deeks SG, Margolis DM, Siliciano RF, Swanstrom R. HIV reservoirs: what, where and how to target them. Nat Rev Microbiol 2016; 14:55-60.
Paiardini M, Lichterfeld M. Follicular T helper cells: hotspots for HIV-1 persistence. Nat Med 2016; 22:711-712.
Setchell BP. The testis and tissue transplantation: historical aspects. J Reprod Immunol 1990; 18:1-8.
Zhao S, Zhu W, Xue S, Han D. Testicular defense systems: immune privilege and innate immunity. Cell Mol Immunol 2014; 11:428-437.
Mujugira A, Coombs RW, Heffron R, Celum C, Ronald A, Mugo N, et al. Seminal HIV-1 RNA detection in heterosexual African men initiating antiretroviral therapy. J Infect Dis 2016; 214: 212-215.
Jenabian M-A, Costiniuk CT, Mehraj V, Ghazawi FM, Fromentin R, Brousseau J, et al. Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIVinfected adults. AIDS 2016; 30:2777-2786.
Chevalier MF, Weiss L. The split personality of regulatory T cells in HIV infection. Blood 2013; 121:29-37.
Robillard KR, Chan GN, Zhang G, la Porte C, Cameron W, Bendayan R. Role of P-glycoprotein in the distribution of the HIV protease inhibitor atazanavir in the brain and male genital tract. Antimicrob Agents Chemother 2014; 58: 1713-1722.
Imaz A, Martinez-Picado J, Niub o J, Kashuba ADM, Ferrer E, Ouchi D, et al. HIV-1-RNA decay and dolutegravir concentrations in semen of patients initiating a first antiretroviral regimen. J Infect Dis 2016 [Epub ahead of print].
Coombs RW, Lockhart D, Ross SO, Deutsch L, Dragavon J, Diem K, et al. Lower genitourinary tract sources of seminal HIV. J Acquir Immune Defic Syndr 2006; 41:430-438.
Stekler J, Sycks BJ, Holte S, Maenza J, Stevens CE, Dragavon J, et al. HIV dynamics in seminal plasma during primary HIV infection. AIDS Res Hum Retroviruses 2008; 24:1269-1274.
Ho YC, Shan L, Hosmane NN, Wang J, Laskey SB, Rosenbloom DI, et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 2013; 155:540-551.
Krieger JN, Nirapathpongporn A, Chaiyaporn M, Peterson G, Nikolaeva I, Akridge R, et al. Vasectomy and human immunodeficiency virus type 1 in semen. J Urol 1998; 159:820-825.
Coombs RW, Krieger JN. Semen remains the way forward to understand HIV-1 infection. J Infect Dis (in press).
